Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q2 2023 Earnings Call Transcript August 17, 2023 Operator: Good morning, and welcome to the Zevra Therapeutics Second Quarter 2023 Corporate and Financial Results Conference Call. [Operator Instructions] Please be advised that today’s call is being recorded. I will now turn the call over to Nichol Ochsner, Zevra Therapeutics Vice President, […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Rating) CFO R. Laduane Clifton bought 2,740 shares of the company’s stock in a transaction dated Thursday, May 18th. The shares were acquired at an average cost of $4.95 per share, for a total transaction of $13,563.00. Following the completion of the transaction, the chief financial officer now owns […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Rating) CFO R. Laduane Clifton bought 2,740 shares of the company’s stock in a transaction that occurred on Thursday, May 18th. The stock was acquired at an average price of $4.95 per share, for a total transaction of $13,563.00. Following the completion of the acquisition, the chief financial officer […]
KemPharm, Inc. (NASDAQ:NASDAQ:KMPH) Q2 2022 Earnings Conference Call August 11, 2022 05:00 PM ET Company Participants Nichol Ochsner - Vice President-Investor Relations & Corporate.